Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study

Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study

Abstract Background Varenicline, bupropion and nicotine replacement therapy (NRT) are three effective pharmacotherapies for smoking cessation, but data about their safety in pregnancy are limited. We assessed the risk of adverse perinatal outcomes and major congenital anomalies associated with the u...

Full description

Bibliographic Details
Main Authors: Duong Thuy Tran, David B. Preen, Kristjana Einarsdottir, Anna Kemp-Casey, Deborah Randall, Louisa R. Jorm, Stephanie K. Y. Choi, Alys Havard
Format: Article
Language:English
Published: BMC 2020-02-01
Series:BMC Medicine
Subjects:
Adverse outcomes
Australia
Birth defects
Bupropion
Nicotine replacement therapy
Pregnancy
Online Access:https://doi.org/10.1186/s12916-019-1472-9

Internet

https://doi.org/10.1186/s12916-019-1472-9

Similar Items